Supplementary Data from Tepotinib Efficacy and Safety in Patients with &lt;i&gt;MET&lt;/i&gt; Exon 14 Skipping NSCLC: Outcomes in Patient Subgroups from the VISION Study with Relevance for Clinical Practice